In May 2012, the AUA presented the updated algorithm of care for overactive bladder. This presentation reviews that algorithm with emphasis on the evidence for practice and the addition of percutaneous tibial nerve stimulation along with the results from the long term STEP study regarding treatment with Urgent PC

Contact hours available until 3/7/2015.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Conflict of Interest Disclosure:
Planning Committee Disclosures:

Donna J. Carrico, WHNP, MS/ Consultant/Presenter Bureau: Uroplasty Inc.
Tamara Dickinson, RN, CURN, CCCN, BCB-PMD/ Advisory Board:Hollister Inc, Seek Wellness

Speaker Disclosures:
Leslie Saltzstein Wooldridge, GNP-BC, CUNP, BCIA, PMDB has disclosed the following relevant relationships with commercial interests:
Grant/Research Support: Uroplasty, EMKinetics
Consultant/Presenter Bureau: Uroplasty, Astellas
Advisory Board: Uroplasty

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Non-Endorsement of Products:
Accreditation of activities for contact hours does not imply approval or endorsement of any product, advertising, or educational content by the Society of Urologic Nurses and Associates (SUNA) or the American Nurses Credentialing Center’s Commission on Accreditation.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Accreditation status does not imply endorsement by the provider or ANCC of any commercial product.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.

Objectives:

Define overactive bladder (OAB) prevalence and its symptoms.
Identify key components of the American Urologic Association (AUA) guidelines for treating OAB.
Describe percutaneous tibial nerve stimulation (PTNS) as the newest addition to OAB treatment regimens.
State current evidence regarding outcomes related to PTNS.